News und Analysen

There’s a new commodity in the financial markets today, and that’s any stock (or business, for that matter) that carries a certain level of immunity to the recent trade tariffs rolled out by

Short-term volatility has been a hallmark of the market in 2025, but one way investors may be able to bypass this concern is by adopting a longer time horizon for their investments. After all, the

The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green in 2025 as of the Apr. 21 close. Shares were down

Investors increasingly seek stable and resilient investments in today's volatile and economically uncertain market. Consequently, it is crucial to

Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing 'off-the-shelf' cancer immunotherapies using

UnitedHealth Group Inc. (NYSE: UNH) is a bellwether for the health insurance industry. The company symbolized the flaws in managed care organizations

AST SpaceMobile Inc. (NASDAQ: ASTS) is developing the world’s first space-based cellular broadband network, with direct-to-device (D2D) technology

Abbott Laboratories (NYSE: ABT) is not immune to the impact of tariffs on its medical device business. However, the company’s diversified business is tariff-resistant, and moves are being made to

Viking Therapeutics Inc. (NASDAQ: VKTX) has taken investors on a wild ride since the beginning of 2024. At one point, VKTX stock was up 375% from its

Johnson & Johnson (NYSE: JNJ) delivered a solid earnings report on April 15.

On the one hand, the company beat on the top and bottom lines and offered